Clinical trials
Withdrawn Phase 1/2 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Wake Forest University Health Sciences | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Bristol-Myers Squibb | 1 |
| Case Comprehensive Cancer Center | 1 |
| Clinical Oncology Research Associates | 1 |
| Criterium, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Elpiscience Biopharma, Ltd. | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 29 |
| Lung Neoplasms | 9 |
| Adenocarcinoma of Lung | 7 |
| Neoplasm Metastasis | 4 |
| Breast Neoplasms | 3 |
| Small Cell Lung Carcinoma | 3 |
| Adenocarcinoma, Bronchiolo-Alveolar | 2 |
| Carcinoma, Transitional Cell | 2 |
| Melanoma | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.